Psychedelic Drugs Market By Drug Type (Psilocybin, Lysergic acid diethylamide, Ketamine, Dimethyltryptamine, Others), By Application (Depression & Anxiety, Post-Traumatic Stress Disorder, Addiction Treatment, Chronic Pain, Others), By Source (Natural Psychedelics, Synthetic Psychedelics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-user (Hospitals & Clinics, Research Institutions, Specialty Centers, Homecare Settings, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Drug Type

• Psilocybin
• Lysergic acid diethylamide
• Ketamine
• Dimethyltryptamine
• Others

By Application

• Depression & Anxiety
• Post-Traumatic Stress Disorder
• Addiction Treatment
• Chronic Pain
• Others

By Source

• Natural Psychedelics
• Synthetic Psychedelics

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

 By End-user

• Hospitals & Clinics
• Research Institutions
• Specialty Centers
• Homecare Settings
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Compass Pathways plc
• MindMed Inc.
• ATAI Life Sciences AG
• Cybin Inc.
• Field Trip Health Ltd.
• GH Research PLC
• Numinus Wellness Inc.
• Seelos Therapeutics, Inc.
• Beckley Psytech Ltd.
• MAPS Public Benefit Corporation
• Delix Therapeutics
• Small Pharma Inc.
• Entheon Biomedical Corp.
• Revive Therapeutics Ltd.
• Terran Biosciences, Inc.